News

C&R Research successfully carried out US FDA approval for the Phase 3 IND clinical trial of 'EYELEA' Biosimilar with Rophibio,…

C&R Research (CEO Moon-Tae Yoon) successfully carried out the US FDA medical device 510(k) approval work, expanding business scope to…

C&R Research, a contract research organization (CRO) is undergoing a complete overhaul of its clinical data collection method. They are…

Moon-Tae Yoon, CEO of C&R Research (359090), is seeing success with his overseas expansion strategy. New orders are consistently increasing…

C&R Research (359090) announced its provisional performance, reporting a 13.7% increase in revenue and a 41.6% increase in net profit…

C&R Research announced on the 29th Jan that it has signed a joint research agreement with the College of Pharmacy at…

C&R Research, a contract research organization (CRO) led by CEO Moon-Tae Yoon, has embarked on global market expansion with the…

"At the end of last year, we established overseas subsidiaries in the United States and Thailand. We aim to increase…

C&R Research received the 'Innovative CRO' certification with the highest score ever in the professional areas of 'Project Management' and…

C&R Research, a contract research organization (CRO), has achieved a new performance record in the third quarter and continues to…